drugset / Trial / NCT03818321

Urinary Track Infection Prevention After Urogynecological Surgery

NCT03818321 ↗

Phase 2 Completed 185 enrolled TriHealth Inc.
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study is randomized double-blinded placebo-controlled trial to access oral Methenamine Hippurate (MH) in combination with cranberry capsules is superior to cranberry capsules alone in prevention of UTI in patients with transient post-operative urinary retention requiring a Foley catheter after pelvic reconstructive surgery.

Timeline

Start
2019-06-17
Primary completion
2021-07-01
Completion
2021-07-01

Outcome

Met primary endpoint

paper placebo group (79.8%) compared with the methenamine group (66.7%; odds ratio, 1.97; 95% confidence interval, 1.01-3.87; P = 0.048). PMID 35272334 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Methenamine Hippurate Unknown 1 g Oral